Topically applied ophthalmic drugs can occasionally produce adverse systemic effects due
to systemic absorption of the drug or impediment of the drug's metabolism. Increasing …

AIM To determine the long term efficacy of monotherapy with topically applied β blocking
agents and to determine whether selective β blockers were able to preserve the visual field …

We evaluated the use of topically administered betaxolol 0.5% in 101 glaucoma patients (47
men and 54 women) who had chronic obstructive pulmonary disease, asthma, or timolol …

Topically administered beta blockers are the preferred medical therapy for glaucoma. These
agents reduce intraocular pressure (IOP), thereby preventing damage to the optic nerve and …

Since the late 1970s, topical β‐adrenergic blockers have been the drugs of choice in
treating ocular hypertension and associated glaucoma. The currently available drugs are …

One hundred seven patients with intraocular, pressures (IOPs) between 22 and 28 mmHg
with normal visual fields on Goldmann perimetry and without evidence of optic nerve …

Synopsis: Timolol maleate 1 is a nonselective β-blocking drug used for the topical treatment
of increased intraocular pressure in patients with chronic open angle glaucoma. In …

Many elderly people tend not to complain in the face of often serious disease but stoically
accept'every tatter in their mortal dress'l as the inevitable price of aging. We, their carers …

• We conducted a randomized, double-masked, long-term clinical trial to determine whether
topical timolol therapy was effective in delaying or preventing the onset of glaucomatous …

Although twice-daily instillation of topical beta-blockers is the standard regimen for treatment
of increased intraocular pressure, once-daily therapy might improve patient compliance and …